Gerber Hans-Peter

Gerber Hans-Peter is listed in filings as CHIEF SCIENTIFIC OFFICER at Sutro Biopharma, Inc.. This profile follows SEC Form 4 activity through Mar 3, 2026, including purchase activity. Recent filings connect the profile to Sutro Biopharma, Inc. (STRO). The current snapshot covers public activity from Sep 20, 2024 to Mar 3, 2026. Reported amounts are shown as $822.0K to $9.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.